Shown: posts 1 to 1 of 1. This is the beginning of the thread.
Posted by sadsuzie on November 19, 2001, at 21:03:50
This is probably old news to most of you, but I thought I'd post it in case anyone is interested.
Somerset Announces Submission of New Drug Application For EMSAM(TM) (Selegiline Transdermal System)
5/25/2001 6:40:24 AM (PRNewswire) -- TAMPA, Fla.,Somerset Pharmaceuticals, Inc.("Somerset"), which is owned 50% by Watson Pharmaceuticals, Inc. (NYSE: WPI) and 50% by Mylan Laboratories, Inc. (NYSE: MYL) today announces the filing of a New Drug Application (NDA) with the United States Food and Drug Administration for registration of its EMSAM(TM) (Selegiline TransdermalSystem) 20mg/20cm2, for the treatment of depression.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.